WednesdayDec 20, 2023 1:23 pm

TinyGemsBreaks – GEMXX Corporation (GEMZ) Amends LOI Closing Deadline, Plans Implementation of Pilot Mine on Yukon Gold Property

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, continues to make progress in its assessments quantifying the proven and potential gold resources on the Yukon Gold property. Currently GEMXX is working closely with the project’s current owners to implement a work plan calling for a pilot mine as soon as weather permits in 2024. With that in mind, the company announced that the closing deadline in the original letter of intent (“LOI”) has been extended. The company believes that the project represents a valuable asset and a return on investment (“ROI”) with proven resources of 2.2 million…

Continue Reading

WednesdayDec 20, 2023 10:24 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Approves Election of Directors During 2023 Annual General Meeting

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2023 annual general meeting. According to the report, during the meeting, which was held on Dec. 19, 2023, all matters considered by shareholders were approved; agenda items were sent to shareholders in a notice of meeting and management information communication that was released on Oct. 27, 2023. In addition, shareholders approved the election of five directors, including Eric A. Adams, Janet Grove, Andrew Hull, Nicole Lemerond and Bryan Baldasare; directors will hold their…

Continue Reading

ThursdayDec 07, 2023 3:42 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) LiDAR Tech Topic of Latest Proactive Video Release

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is in the spotlight. Cepton senior vice president of product Brunno Moretti is the featured guest on the latest video interview from Proactive. During the segment, Moretti and Proactive host Steve Darling talked about how Cepton’s proprietary LiDAR tech is revolutionizing truck safety. Noting that the sheer size and weight of semi-trucks create challenges, Moretti explained the need for effective detection systems, especially for autonomous and advanced driver-assistance systems. Cepton’s LiDAR is capable of detecting small objects as far away as 300 meters, providing comprehensive coverage around the…

Continue Reading

ThursdayDec 07, 2023 1:26 pm

TinyGemsBreaks – Diamond Lake Minerals Inc. (DLMI) Announced Global Media Leader as New Strategic Advisor

Diamond Lake Minerals (OTC: DLMI), a forward-thinking, multistrategy operating company specializing in digital assets and SEC-registered security tokens, has added Marty Pompadur to its expert team of advisors. Throughout his career in the media and entertainment space, Pompadur has served in a variety of leadership roles, garnering a wealth of expertise and insight that will serve the company well. While he began his career as an attorney, he quickly transitioned into the media field, working for American Broadcasting Companies Inc. (“ABC”) in a variety of roles during his 17 years there, ultimately becoming the youngest member appointed to the organization’s…

Continue Reading

WednesdayDec 06, 2023 3:34 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Filing of Landmark Federal Spoofing Lawsuit

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its filing of a complaint in the United States District Court for the Southern District of New York alleging that UBS Securities, LLC, IMC Financial Markets and Clear Street Markets, LLC (the “Defendants”) engaged in a market manipulation scheme that violated Section 10(b) and Rule 10b-5(a) and (c) and Section 9(a) of the Securities Exchange Act of 1934. The lawsuit alleges that between Nov. 9, 2021, and Nov. 9, 2023, the Defendants and/or their customers used spoofing to manipulate the market price of Mullen shares. “In the 21…

Continue Reading

WednesdayDec 06, 2023 12:32 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Interim Analysis on Global Berubicin Trial Showing Promising Results

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. In September, the company announced that 200 out of 243 expected patients had been enrolled in its ongoing study evaluating the effectiveness of Berubicin for recurrent glioblastoma (“GBM”), a highly aggressive and incurable form of brain cancer. The critical and adaptive global trial involves multiple centers and is open-label, randomized and controlled, comparing Berubicin to Lomustine - the standard of care - in adult patients with recurrent GBM (“WHO Grade IV”) after standard first-line therapy has failed. The…

Continue Reading

MondayDec 04, 2023 1:36 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Strategic Engagement of Basile Law Firm P.C.

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has hired Mark R. Basile, Esq. and his law firm, The Basile Law Firm P.C., to assist the company in reviewing its current fundings and to make recommendations in developing its floorplan for future fundings. “Mullen is committed to full transparency to the public markets. We are making this announcement in an effort to notify our shareholders that we fully intend to take any and all measures necessary to continue our sustainable growth as we move ahead with previously announced strategic initiatives,” said David Michery, CEO…

Continue Reading

MondayDec 04, 2023 11:56 am

TinyGemsBreaks — Vision Marine Technologies Inc. (NASDAQ: VMAR), Blue Water Boat Rental Partner in Florida Expansion Offering E-Motion(TM)-Equipped Rentals

Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, is partnering with Blue Water Boat Rental to expand into Riviera Beach, Florida. The company’s new operation is a “key milestone” in a strategic plan to broaden the reach and impact of sustainable electric boating. VMAR’s new Riviera Beach location, which is located near Peanut Island and benefits from Florida's year-round boating climate, is scheduled to open this month. In a first for the company, the location will offer the revolutionary E-Motion(TM) 180E Powertrain System to renters. A leader in internal combustion engine…

Continue Reading

TuesdayNov 28, 2023 11:48 am

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Tech Lowers Blood Glucose More Effectively than Branded GLP-1 drug Semaglutide Alone, Study Shows

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting additional positive interim results from its human pilot study evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially as Rybelsus(R). According to the report, DehydraTECH-powered semaglutide sustained lower levels of blood glucose from baseline including nearly 10 times lower after 24 hours as well as lower blood-glucose spikes after eating. The company noted that this was the first-ever DehydraTECH test with a “large molecule” drug. According to the report, the study was conducted by a prominent university research center comparing a single…

Continue Reading

MondayNov 27, 2023 2:07 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Improve Oral Performance of GLP-1 Drug in Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced positive interim results from a human pilot study currently underway evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, which is available commercially in the branded product Rybelsus(R). A prominent university research center is performing the study, comparing a single 7 mg semaglutide dose of a Rybelsus tablet (“control”) to a matching dose from Rybelsus that had been compound formulated in capsule form using DehydraTECH processing technology enhancements (“DehydraTECH GLP-1”). According to the update, blood was examined by a third-party laboratory…

Continue Reading

Contact us: (512) 354-7000